Pancreatic Cancer: Pancreatica - 2003: January - February

Pancreatic Cancer News and Archives

For access to the Select Abstracts^sm section, please click here

For educational purposes only; not to be relied upon. Please read Pancreatica Disclaimer

2003 First Quarter

Physical Activity, Body Weight, and Pancreatic Cancer Mortality
March 10, 2003
...more

Aphton Presented Phase III Data for Monotherapy with G17DT for Advanced Pancreatic Cancer Patients to Overseas Regulatory Agency
March 4, 2003
...more

A Case Report of Adjuvant Chemotherapy (TS-1) for Far Advanced Gastric Cancer In Which The Patient Maintained a Good Quality of Life
March 1, 2003
...more

Adjuvant and Additive Therapy for Cancer of the Pancreas
March 1, 2003
...more

Angiogenesis Inhibition with TNP-470, 2-Methoxyestradiol, and Paclitaxel in Experimental Pancreatic Carcinoma
March 1, 2003
...more

An Open Phase I Study Assessing the Feasibility of the Triple Combination: Oxaliplatin Plus Irinotecan Plus Leucovorin/ 5-Fluorouracil Every 2 Weeks in Patients with Advanced Solid Tumors
March 1, 2003
...more

Antitumor Activity of Virulizin, a Novel Biological Response Modifier (BRM) in a Panel of Human Pancreatic Cancer and Melanoma Xenografts
March 1, 2003
...more

A Phase II Study of Docetaxel-Irinotecan Combination in Advanced Pancreatic Cancer
March 1, 2003
...more

CA 19-9 in the Therapy Monitoring and Follow-up of Locally Advanced Cancer of the Exocrine Pancreas Treated with Radiochemotherapy
March 1, 2003
...more

Epidermal Growth Factor Receptor Expression in Human Pancreatic Cancer: Significance for Liver Metastasis
March 1, 2003
...more

Farnesyltransferase Inhibitors--A Novel Approach in the Treatment of Advanced Pancreatic Carcinomas
March 1, 2003
...more

Hyperfractionated Radiotherapy and Paclitaxel for Locally Advanced/Unresectable Pancreatic Cancer
March 1, 2003
...more

Inhibition of the Phosphatidylinositol 3'-Kinase Signaling Pathway Increases the Responsiveness of Pancreatic Carcinoma Cells to Sulindac
March 1, 2003
...more

In Vivo Induction of Dendritic Cell-Mediated Cytotoxicity Against Allogeneic Pancreatic Carcinoma Cells
March 1, 2003
...more

Long-term Results of Partial Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreatic Head: 25-Year Experience
March 1, 2003
...more

Occupational Exposures and Gastrointestinal Cancers Among Finnish Women
March 1, 2003
...more

Overexpression of Pancreatitis-Associated Protein (PAP) in Human Pancreatic Ductal Adenocarcinoma
March 1, 2003
...more

Pancreatic Cancer. The Relative Importance of Neoadjuvant Therapy
March 1, 2003
...more

Regional Celiac Artery Infusion in the Adjuvant Treatment of Pancreatic Cancer
March 1, 2003
...more

Sentinel Lymph Node Navigation Surgery for Pancreatic Head Cancers
March 1, 2003
...more

Sequential Polychemotherapy in Exocrine Pancreatic Cancer
March 1, 2003
...more

Significance of Detection of K-ras Gene Mutations and CA19-9 in Serum for Diagnosis of Pancreatic Carcinoma
March 1, 2003
...more

Treatment of Pancreatic Cancer with a Combination of Irinotecan (CPT-11) and Gemcitabine: A Multicenter Phase II Study by the Greek Cooperative Group for Pancreatic Cancer
March 1, 2003
...more

Treatment of Inoperable Pancreatic Carcinoma Using a Cell-Based Local Chemotherapy: Results of a Phase I / II Clinical Trial
March 1, 2003
...more

Virtual Pancreatoscopy of Pancreatic Cancer
March 1, 2003
...more

Can Intestinal Innervation be Preserved in Pancreatoduodenectomy for Cancer? Results of an Anatomical Study
February 25, 2003
...more

A 5-Decade Analysis of 13,715 Carcinoid Tumors
February 15, 2003
...more

SuperGen Submits Second Module of Orathecin's 'Rolling' New Drug Application as an Oral Treatment for Pancreatic Cancer
February 7, 2003
...more

ICACT: Intra-Arterial Chemotherapy Improves Survival in Patients with Pancreatic Cancer
February 6, 2003
...more

BRCA2 Germline Mutations in Familial Pancreatic Carcinoma
February 5, 2003
...more

A Case of Advanced Pancreatic Cancer with Multiple Liver Metastasis that Improved Remarkably with Use of Low-Dose Cisplatin and TS-1
February 1, 2003
...more

A Phase I/II Trial of Intratumoral Endoscopic Ultrasound Injection of ONYX-015 with Intravenous Gemcitabine in Unresectable Pancreatic Carcinoma
February 1, 2003
...more

Chemoradiation of Unresectable Pancreatic Carcinoma: Impact of Pretreatment Hemoglobin Level on Patterns of Failure
February 1, 2003
...more

Epidemiology of Pancreatic Cancer: An Overview
February 1, 2003
...more

Evaluation of Vascular Endothelial Growth Factor Blockade and Matrix Metalloproteinase Inhibition as a Combination Therapy for Experimental Human Pancreatic Cancer
February 1, 2003
...more

Familial and Second Primary Pancreatic Cancers: A Nationwide Epidemiologic Study from Sweden
February 1, 2003
...more

Impact of Intraoperative Radiation on Postoperative and Disease-Specific Outcome after Pancreatoduodenectomy for Adenocarcinoma: A Propensity Score Aanalysis
February 1, 2003
...more

Influence of Specialization on the Management and Outcome of Patients with Pancreatic Cancer
February 1, 2003
...more

Duodenal-Preserving Resection of the Head of the Pancreas and Pancreatic Head Resection with Second-Portion Duodenectomy for Benign Lesions, Low-Grade Malignancies, and Early Carcinoma Involving the Periampullary Region
February 1, 2003
...more

Molecular Progression of Promoter Methylation in Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas
February 1, 2003
...more

p53 Alteration Is Not An Independent Prognostic Indicator, But Affects the Efficacy of Adjuvant Chemotherapy in Human Pancreatic Cancer
February 1, 2003
...more

Pancreatic Leak After Left Pancreatectomy is Reduced Following Main Pancreatic Duct Ligation
February 1, 2003
...more

Pancreaticoduodenectomy. Role of Interventional Radiologists in Managing Patients and Complications
February 1, 2003
...more

Radiochemotherapy with Gemcitabine and Cisplatin in Pancreatic Cancer - Feasible and Effective
February 1, 2003
...more

Robotic Resection of Pancreatic Neuroendocrine Tumor
February 1, 2003
...more

Surgical Resection after Preoperative Chemoradiotherapy Benefits Selected Patients with Unresectable Pancreatic Cancer
February 1, 2003
...more

Weekly Gemcitabine and Cisplatin Chemotherapy: A Well-Tolerated but Ineffective Chemotherapeutic Regimen in Advanced Pancreatic Cancer Patients A Report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
February 1, 2003
...more

Influence of Hypoxia and Neoangiogenesis on the Growth of Pancreatic Cancer
January 22, 2003
...more

Pancreatic Cancer in vitro Toxicity Mediated by Chinese Herbs SPES and PC-SPES: Implications for Monotherapy and Combination Treatment
January 10, 2003
...more

The MUC Gene Family: Their Role in Diagnosis and Early Detection of Pancreatic Cancer
January 7, 2003
...more

Biweekly High-Dose Gemcitabine Alone or in Combination with Capecitabine in Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial
January 1, 2003
...more

Clinicopathologic Analysis of Pancreatic Adenocarcinoma in African Americans and Caucasians
January 1, 2003
...more

Circulating Anti-MUC1 IgG Antibodies as a Favorable Prognostic Factor for Pancreatic Cancer
January 1, 2003
...more

Combining Capecitabine and Gemcitabine in Patients With Advanced Pancreatic Carcinoma: A Phase I/II Trial
January 1, 2003
...more

Cost-Effectiveness of Pancreatic Cancer Screening in Familial Pancreatic Cancer Kindreds
January 1, 2003
...more

Differentiation of Neuroendocrine Tumors from Other Pancreatic Lesions by Echo-Enhanced Power Doppler Sonography and Somatostatin Receptor Scintigraphy
January 1, 2003
...more

Diagnostic Accuracy of Endoscopic Ultrasound-Guided Fine-Needle Aspiration in Patients with Presumed Pancreatic Cancer
January 1, 2003
...more

Function of Nuclear Factor kappaB in Pancreatic Cancer Metastasis
January 1, 2003
...more

Pancreaticoduodenectomy (Whipple Resections) in Patients without Malignancy: Are They All 'Chronic Pancreatitis'?
January 1, 2003
...more

Peripancreatic Artery Ligation and Artery Infusion Chemotherapy for Advanced Pancreatic Carcinoma
January 1, 2003
...more

Phase I Trial of Strictly Time-Scheduled Gemcitabine and Cisplatin with Concurrent Radiotherapy in Patients with Locally Advanced Pancreatic Cancer
January 1, 2003
...more

Potential Involvement of the Cyclooxygenase-2 Pathway in the Regulation of Tumor-associated Angiogenesis and Growth in Pancreatic Cancer
January 1, 2003
...more

Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma: A Population-Based, Linked Database Analysis of 396 Patients
January 1, 2003
...more

Restoring Apoptosis in Pancreatic Cancer Cells by Targeting the Nuclear Factor-kappaB Signaling Pathway With the Anti-Epidermal Growth Factor Antibody IMC-C225
January 1, 2003
...more

Standard vs. Radical Pancreaticoduodenectomy for Periampullary Adenocarcinoma. A Prospective, Randomized Trial Evaluating Quality of Life in Pancreaticoduodenectomy Survivors
January 1, 2003
...more

Synergistic Cytotoxic Effect of TRAIL and Gemcitabine in Pancreatic Cancer Cells
January 1, 2003
...more

The Selective Cyclooxygenase-2 Inhibitor Nimesulide Induces Apoptosis in Pancreatic Cancer Cells Independent of COX-2
January 1, 2003
...more

Weekly Gemcitabine and 24-Hour Infusional 5-Fluorouracil in Advanced Pancreatic Cancer: A Phase I-II Study
January 1, 2003
...more

Why Do Black Americans Have a Higher Risk of Pancreatic Cancer than White Americans?
January 1, 2003
...more

For educational purposes only; not to be relied upon
Please read Pancreatica Disclaimer

Home | In The News | Links | Newswire | Donations
FAQ | Clinical Trials Database | Research Resources | About Us

webmaster

©2000-2008 Pancreatica.org - All Rights Reserved
www.pancreatica.org

	Pancreatic Cancer News and Archives *For access to the Select Abstracts^sm section, please click here* For educational purposes only; not to be relied upon. Please read Pancreatica Disclaimer 2003 First Quarter Physical Activity, Body Weight, and Pancreatic Cancer Mortality March 10, 2003 ...more Aphton Presented Phase III Data for Monotherapy with G17DT for Advanced Pancreatic Cancer Patients to Overseas Regulatory Agency March 4, 2003 ...more A Case Report of Adjuvant Chemotherapy (TS-1) for Far Advanced Gastric Cancer In Which The Patient Maintained a Good Quality of Life March 1, 2003 ...more Adjuvant and Additive Therapy for Cancer of the Pancreas March 1, 2003 ...more Angiogenesis Inhibition with TNP-470, 2-Methoxyestradiol, and Paclitaxel in Experimental Pancreatic Carcinoma March 1, 2003 ...more An Open Phase I Study Assessing the Feasibility of the Triple Combination: Oxaliplatin Plus Irinotecan Plus Leucovorin/ 5-Fluorouracil Every 2 Weeks in Patients with Advanced Solid Tumors March 1, 2003 ...more Antitumor Activity of Virulizin, a Novel Biological Response Modifier (BRM) in a Panel of Human Pancreatic Cancer and Melanoma Xenografts March 1, 2003 ...more A Phase II Study of Docetaxel-Irinotecan Combination in Advanced Pancreatic Cancer March 1, 2003 ...more CA 19-9 in the Therapy Monitoring and Follow-up of Locally Advanced Cancer of the Exocrine Pancreas Treated with Radiochemotherapy March 1, 2003 ...more Epidermal Growth Factor Receptor Expression in Human Pancreatic Cancer: Significance for Liver Metastasis March 1, 2003 ...more Farnesyltransferase Inhibitors--A Novel Approach in the Treatment of Advanced Pancreatic Carcinomas March 1, 2003 ...more Hyperfractionated Radiotherapy and Paclitaxel for Locally Advanced/Unresectable Pancreatic Cancer March 1, 2003 ...more Inhibition of the Phosphatidylinositol 3'-Kinase Signaling Pathway Increases the Responsiveness of Pancreatic Carcinoma Cells to Sulindac March 1, 2003 ...more In Vivo Induction of Dendritic Cell-Mediated Cytotoxicity Against Allogeneic Pancreatic Carcinoma Cells March 1, 2003 ...more Long-term Results of Partial Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreatic Head: 25-Year Experience March 1, 2003 ...more Occupational Exposures and Gastrointestinal Cancers Among Finnish Women March 1, 2003 ...more Overexpression of Pancreatitis-Associated Protein (PAP) in Human Pancreatic Ductal Adenocarcinoma March 1, 2003 ...more Pancreatic Cancer. The Relative Importance of Neoadjuvant Therapy March 1, 2003 ...more Regional Celiac Artery Infusion in the Adjuvant Treatment of Pancreatic Cancer March 1, 2003 ...more Sentinel Lymph Node Navigation Surgery for Pancreatic Head Cancers March 1, 2003 ...more Sequential Polychemotherapy in Exocrine Pancreatic Cancer March 1, 2003 ...more Significance of Detection of K-ras Gene Mutations and CA19-9 in Serum for Diagnosis of Pancreatic Carcinoma March 1, 2003 ...more Treatment of Pancreatic Cancer with a Combination of Irinotecan (CPT-11) and Gemcitabine: A Multicenter Phase II Study by the Greek Cooperative Group for Pancreatic Cancer March 1, 2003 ...more Treatment of Inoperable Pancreatic Carcinoma Using a Cell-Based Local Chemotherapy: Results of a Phase I / II Clinical Trial March 1, 2003 ...more Virtual Pancreatoscopy of Pancreatic Cancer March 1, 2003 ...more Can Intestinal Innervation be Preserved in Pancreatoduodenectomy for Cancer? Results of an Anatomical Study February 25, 2003 ...more A 5-Decade Analysis of 13,715 Carcinoid Tumors February 15, 2003 ...more SuperGen Submits Second Module of Orathecin's 'Rolling' New Drug Application as an Oral Treatment for Pancreatic Cancer February 7, 2003 ...more ICACT: Intra-Arterial Chemotherapy Improves Survival in Patients with Pancreatic Cancer February 6, 2003 ...more BRCA2 Germline Mutations in Familial Pancreatic Carcinoma February 5, 2003 ...more A Case of Advanced Pancreatic Cancer with Multiple Liver Metastasis that Improved Remarkably with Use of Low-Dose Cisplatin and TS-1 February 1, 2003 ...more A Phase I/II Trial of Intratumoral Endoscopic Ultrasound Injection of ONYX-015 with Intravenous Gemcitabine in Unresectable Pancreatic Carcinoma February 1, 2003 ...more Chemoradiation of Unresectable Pancreatic Carcinoma: Impact of Pretreatment Hemoglobin Level on Patterns of Failure February 1, 2003 ...more Epidemiology of Pancreatic Cancer: An Overview February 1, 2003 ...more Evaluation of Vascular Endothelial Growth Factor Blockade and Matrix Metalloproteinase Inhibition as a Combination Therapy for Experimental Human Pancreatic Cancer February 1, 2003 ...more Familial and Second Primary Pancreatic Cancers: A Nationwide Epidemiologic Study from Sweden February 1, 2003 ...more Impact of Intraoperative Radiation on Postoperative and Disease-Specific Outcome after Pancreatoduodenectomy for Adenocarcinoma: A Propensity Score Aanalysis February 1, 2003 ...more Influence of Specialization on the Management and Outcome of Patients with Pancreatic Cancer February 1, 2003 ...more Duodenal-Preserving Resection of the Head of the Pancreas and Pancreatic Head Resection with Second-Portion Duodenectomy for Benign Lesions, Low-Grade Malignancies, and Early Carcinoma Involving the Periampullary Region February 1, 2003 ...more Molecular Progression of Promoter Methylation in Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas February 1, 2003 ...more p53 Alteration Is Not An Independent Prognostic Indicator, But Affects the Efficacy of Adjuvant Chemotherapy in Human Pancreatic Cancer February 1, 2003 ...more Pancreatic Leak After Left Pancreatectomy is Reduced Following Main Pancreatic Duct Ligation February 1, 2003 ...more Pancreaticoduodenectomy. Role of Interventional Radiologists in Managing Patients and Complications February 1, 2003 ...more Radiochemotherapy with Gemcitabine and Cisplatin in Pancreatic Cancer - Feasible and Effective February 1, 2003 ...more Robotic Resection of Pancreatic Neuroendocrine Tumor February 1, 2003 ...more Surgical Resection after Preoperative Chemoradiotherapy Benefits Selected Patients with Unresectable Pancreatic Cancer February 1, 2003 ...more Weekly Gemcitabine and Cisplatin Chemotherapy: A Well-Tolerated but Ineffective Chemotherapeutic Regimen in Advanced Pancreatic Cancer Patients A Report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD) February 1, 2003 ...more Influence of Hypoxia and Neoangiogenesis on the Growth of Pancreatic Cancer January 22, 2003 ...more Pancreatic Cancer in vitro Toxicity Mediated by Chinese Herbs SPES and PC-SPES: Implications for Monotherapy and Combination Treatment January 10, 2003 ...more The MUC Gene Family: Their Role in Diagnosis and Early Detection of Pancreatic Cancer January 7, 2003 ...more Biweekly High-Dose Gemcitabine Alone or in Combination with Capecitabine in Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial January 1, 2003 ...more Clinicopathologic Analysis of Pancreatic Adenocarcinoma in African Americans and Caucasians January 1, 2003 ...more Circulating Anti-MUC1 IgG Antibodies as a Favorable Prognostic Factor for Pancreatic Cancer January 1, 2003 ...more Combining Capecitabine and Gemcitabine in Patients With Advanced Pancreatic Carcinoma: A Phase I/II Trial January 1, 2003 ...more Cost-Effectiveness of Pancreatic Cancer Screening in Familial Pancreatic Cancer Kindreds January 1, 2003 ...more Differentiation of Neuroendocrine Tumors from Other Pancreatic Lesions by Echo-Enhanced Power Doppler Sonography and Somatostatin Receptor Scintigraphy January 1, 2003 ...more Diagnostic Accuracy of Endoscopic Ultrasound-Guided Fine-Needle Aspiration in Patients with Presumed Pancreatic Cancer January 1, 2003 ...more Function of Nuclear Factor kappaB in Pancreatic Cancer Metastasis January 1, 2003 ...more Pancreaticoduodenectomy (Whipple Resections) in Patients without Malignancy: Are They All 'Chronic Pancreatitis'? January 1, 2003 ...more Peripancreatic Artery Ligation and Artery Infusion Chemotherapy for Advanced Pancreatic Carcinoma January 1, 2003 ...more Phase I Trial of Strictly Time-Scheduled Gemcitabine and Cisplatin with Concurrent Radiotherapy in Patients with Locally Advanced Pancreatic Cancer January 1, 2003 ...more Potential Involvement of the Cyclooxygenase-2 Pathway in the Regulation of Tumor-associated Angiogenesis and Growth in Pancreatic Cancer January 1, 2003 ...more Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma: A Population-Based, Linked Database Analysis of 396 Patients January 1, 2003 ...more Restoring Apoptosis in Pancreatic Cancer Cells by Targeting the Nuclear Factor-kappaB Signaling Pathway With the Anti-Epidermal Growth Factor Antibody IMC-C225 January 1, 2003 ...more Standard vs. Radical Pancreaticoduodenectomy for Periampullary Adenocarcinoma. A Prospective, Randomized Trial Evaluating Quality of Life in Pancreaticoduodenectomy Survivors January 1, 2003 ...more Synergistic Cytotoxic Effect of TRAIL and Gemcitabine in Pancreatic Cancer Cells January 1, 2003 ...more The Selective Cyclooxygenase-2 Inhibitor Nimesulide Induces Apoptosis in Pancreatic Cancer Cells Independent of COX-2 January 1, 2003 ...more Weekly Gemcitabine and 24-Hour Infusional 5-Fluorouracil in Advanced Pancreatic Cancer: A Phase I-II Study January 1, 2003 ...more Why Do Black Americans Have a Higher Risk of Pancreatic Cancer than White Americans? January 1, 2003 ...more

	For educational purposes only; not to be relied upon Please read Pancreatica Disclaimer


	Home \| In The News \| Links \| Newswire \| Donations FAQ \| Clinical Trials Database \| Research Resources \| About Us

	webmaster

	©2000-2008 Pancreatica.org - All Rights Reserved www.pancreatica.org